reviewEP EuropaceMar 1, 2025GREEN OA

Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association

WDWolfram DoehnerGBGiuseppe BorianiTPTatjana PotparaCBCarina Blomström‐LundqvistRPRod Passman

German Centre for Cardiovascular Research · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · +38 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Atrial fibrillation (AF) is one of the most common cardiac diseases and a complicating comorbidity for multiple associated diseases. Many clinical decisions regarding AF are currently based on the binary recognition of AF being present or absent with the categorical appraisal of AF as continued or intermittent. Assessment of AF in clinical trials is largely limited to the time to (first) detection of an AF episode. Substantial evidence shows, however, that the quantitative characteristic of intermittent AF has a relevant impact on symptoms, onset, and progression of AF and AF-related outcomes, including mortality. Atrial fibrillation burden is increasingly recognized as a suitable quantitative measure of…

Citation impact

71
total citations
FWCI
78.04
Percentile
100%
References
138
Citations per year

Authors

21

Topics & keywords

Topics
Keywords
  • Atrial fibrillation
  • Heart Rhythm
  • Medicine
  • Stroke (engine)
  • Clinical Practice
  • Cardiology
  • Internal medicine
  • Statement (logic)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding